Search
-
News
Researchers at Memorial Sloan Kettering (MSK) reported results, which were highlighted at the American Society of Clinical Oncology (ASCO) press cast, that eight weeks of acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia in cancer survivors. While both acupuncture and CBT-I resulted in clinically meaningful and durable effects among this group, CBT-I was more effective, especially among people with mild insomnia symptoms.
… Wednesday, May 16, 2018 Researchers at Memorial Sloan Kettering (MSK) reported results, which were highlighted at the American Society of Clinical Oncology (ASCO) press cast, that eight weeks of acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia in cancer
-
News
New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.
… Monday, October 6, 2008 New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently
-
News
As 2019 comes to an end, take a moment to reflect on the science stories that made the year one to remember.
… Monday, December 16, 2019 Many medical breakthroughs blossom from the seeds of basic science research. This past year, Memorial Sloan Kettering scientists made fundamental discoveries in several basic science fields, including cell biology, molecular biology, developmental biology, and more. Much of
-
News
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed 16 students to our annual Summer Undergraduate Research Program.
… Tuesday, June 14, 2016 Sixteen undergraduate students arrived on June 6, 2016, to begin their Summer Undergraduate Research Program (SURP) under the auspices of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. They were greeted by GSK Associate Dean Linda Burnley and SURP faculty
-
MSK News
Craig B. Thompson, Lisa DeAngelis, and Joan Massagué write that as we mark the 50th year of the War on Cancer and look to the future, our mission at Memorial Sloan Kettering is nothing less than conquering the most urgent challenge: preventing cancer’s spread.
… Thursday, July 1, 2021 Dear MSK Community, These are the four most frightening words for a patient to hear: “Your cancer is back.” As we mark the 50th year of the War on Cancer and look to the future, our mission at Memorial Sloan Kettering is nothing less than conquering the most urgent challenge: preventing
-
News
MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults.
… Wednesday, January 20, 2016 Summary MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults. While cure rates for the disease are high, the standard treatment often results in serious side effects that
-
News
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
… Wednesday, January 24, 2018 Summary Researchers are increasingly drawn to the study of metabolism , the collective suite of chemical reactions occurring in cells, for answers to questions about cancer. A new searchable database aids that quest. Scientists from Memorial Sloan Kettering and the Dana-Farber
-
Newsroom
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
… Monday, February 10, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: MSK Board of Trustees Member David M. Rubenstein Received the Presidential Medal of Freedom David M. Rubenstein Board of Trustees member David M. Rubenstein received the Presidential
-
MSK News
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
… Friday, January 1, 2021 In the spring of 2021, Mark Denisiuk began feeling unwell. He had a sore throat and was always congested. His doctor diagnosed a sinus infection. Then Mark started having night sweats and extreme fatigue. “In the past, I had always powered through any illness I had, but the night
-
News
Nine students will don caps and gowns to celebrate their academic achievements and receive their PhDs from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).
… Tuesday, May 29, 2018 Summary The Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at Memorial Sloan Kettering will award doctorate degrees to nine students tomorrow. Founded in 2006, the school prepares the next generation of scientists to take on real-world clinical challenges through